The Lung Transplant Risk Model - A Nationally Validated Tool for Pre-Transplant Risk Assessment von Chan, E.Y, Nguyen, D.T, Sinha, N, Kaleekal, T.S, Goodarzi, A, Youssef, J.G, Bruckner, B.A, Suarez, E.E, Scheinin, S.A, Graviss, E.A, Gaber, A.O

Volltext

Antibody Mediated Rejection of Unrelated Donor Lung von Fekete, A.A., Yau, S.W., Youssef, J.G., Goodarzi, A., Huang, H.J.

Volltext

CMV Pneumonitis After Discontinuation of Prophylaxis Therapy Guided by CMV T-cell Immunity Panel von Nguyen, M., Pham, C., Pierce, B.J., Yau, S.W., Goodarzi, A., Youssef, J.G., Huang, H.J.

Volltext

Single Lung Transplantation for Pulmonary Fibrosis Secondary to COVID-19 von He, Y.A., Chihara, R.K., Suarez, E.E., Huang, H.J., Goodarzi, A., Yau, S.W., Youssef, J.G., Gaber, A.O., MacGillivray, T.E., Chan, E.Y.

Volltext

Identification of Epstein-Barr Virus Related Risk Factors for the Occurrence of Post-Transplant Lymphoproliferative Disorder in Lung Transplant Recipients von Pierce, B.J., Allen, E., Pham, C., Nguyen, D.T., Graviss, E.A., Goodarzi, A., Yau, S.W., Youssef, J.G., Huang, H.J.

Volltext

Time to Therapeutic Tacrolimus Levels and Association with Acute Cellular Rejection and De Novo Donor-Specific Antibody Development in Lung Transplant Recipients von Dinunno, C.V., Pham, C., Pierce, B., Nguyen, D.T., Graviss, E.A., Huang, H.J., Goodarzi, A., Yau, S.W., Youssef, J.G.

Volltext

Safety of Cumulative Dose Anti-Thymocyte Globulin in Lung Transplant von Pham, C., Chaplain, A., Pierce, B.J., Nguyen, D.T., Graviss, E.A., Goodarzi, A., Yau, S.W., Youssef, J.G., Huang, H.J.

Volltext

Rapid Clinical Recovery from Critical COVID-19 Pneumonia with Vasoactive Intestinal Peptide Treatment von Beshay, S., Youssef, J.G., Zahiruddin, F., Al-Saadi, M., Yau, S., Goodarzi, A., Huang, H., Javitt, J.

Volltext

Use of a Medication Questionnaire to Identify Lung Transplant Recipients Benefiting from Pharmacist Prioritization in Clinic von Pham, C., Nguyen, M., Cooper, M., Pierce, B.J., Harvey, D., Yau, S.W., Youssef, J.G., Goodarzi, A., Nguyen, D.T., Graviss, E.A., Huang, H.J.

Volltext

Long-term follow up of a double-blind, randomized, placebo-controlled trial of Cyclosporine Inhalation Solution (CyIS) in lung transplant recipients von Iacono, A.T., Capra, W.B., Shrewsbury, S.B., Johnson, B.A., Grgurich, W.F., Corcoran, T.E., Youssef, J.G., Smith-Seiler, D.A., Smaldone, G.C., Zeevi, A., Yousem, S.A., Fung, J.J., Dauber, J.H., Burckart, G.J., Griffith, B., McCurry, K.R.

Volltext

A randomized trial of early administration of inhaled cyclosporine in lung transplant recipients von Iacono, A.T, Johnson, B.A, Corcoran, T.E, Smith, D.A, Grgurich, W.F, Dauber, J.H, McCurry, K.R, Zeevi, A, Burckart, G.J, Youssef, J.G, Vensak, J.L, Smaldone, G.C, Fung, J.J, Griffith, B.P

Volltext

Aerosolized cyclosporine as an alternative immunosuppressant in post lung transplant lymphoproliferative disease von Gilbert, S, Iacono, A.T, Grgurich, W.F, Dauber, J.H, Johnson, B.A, Corcoran, T.E, Smith, D.A, Youssef, J.G, Bermudez, C.A, McCurry, K.R

Volltext

Evaluation of plasma levels of NFL, GFAP, UCHL1 and tau as Parkinson's disease biomarkers using multiplexed single molecule counting von Youssef, Priscilla, Hughes, Laura, Kim, Woojin S., Halliday, Glenda M., Lewis, Simon J. G., Cooper, Antony, Dzamko, Nicolas

Volltext

Energy saving potential of high temperature heat pumps in the UK Food and Drink sector von Cooper, Samuel JG, Hammond, Geoffrey P, Hewitt, Neil, Norman, Jonathan B, Tassou, Savvas A, Youssef, Walid

Volltext

Epigallocatechin-3 Gallate Inhibits STAT-1/JAK2/IRF-1/HLA-DR/HLA-B and Reduces CD8 MKG2D Lymphocytes of Alopecia Areata Patients von Hamed, Fatma N, McDonagh, Andrew J G, Almaghrabi, Sarah, Bakri, Youssef, Messenger, Andrew G, Tazi-Ahnini, Rachid

Volltext

Switch maintenance gemcitabine after first-line chemotherapy in patients with malignant mesothelioma: A multicenter open label phase II trial (NVALT19) von Burgers, S.A., de Gooijer, C., Cornelissen, R., Aerts, J.G., Biesma, B., Heemst, R.V., Youssef-El Soud, M., Groen, H.J.M., Staal-van den Brekel, A.J., Bootsma, G., Schijen, J H E M, Baas, P., Giovannetti, E., de Vries, J.F., Hogenboom, F.A., de Wit, D.C.M., Mahn- Schaefers, M.C.W., Lalezari, F., van de Noort, V., Stigt, J.

Volltext

LBA92 - Switch maintenance gemcitabine after first-line chemotherapy in patients with malignant mesothelioma: A multicenter open label phase II trial (NVALT19) von Burgers, S.A., de Gooijer, C., Cornelissen, R., Aerts, J.G., Biesma, B., Heemst, R.V., Youssef-El Soud, M., Groen, H.J.M., Staal-van den Brekel, A.J., Bootsma, G., Schijen, J H E M, Baas, P., Giovannetti, E., de Vries, J.F., Hogenboom, F.A., de Wit, D.C.M., Mahn- Schaefers, M.C.W., Lalezari, F., van de Noort, V., Stigt, J.

Volltext

Whole Genome Sequencing in an Acrodermatitis Enteropathica Family from the Middle East von Tazi-Ahnini, Rachid, Bakri, Youssef, Cooper-Knock, Johnathan, Messenger, Andrew G., McDonagh, Andrew J. G., Pooranachandran, Vivetha, Abu-Duhier, Faisel, Heath, Paul R.

Volltext

Pulmonary lymphangiectasia revisited von Bouchard, S., Di Lorenzo, M., Youssef, S., Simard, P., Lapierre, J.G.

Volltext

Switch-maintenance gemcitabine after first-line chemotherapy in patients with malignant mesothelioma (NVALT19): an investigator-initiated, randomised, open-label, phase 2 trial von Gooijer, C.J. de, Noort, V. van der, Stigt, J.A., Baas, P., Biesma, B., Cornelissen, R., Walree, N. van, Heemst, R.C. van, Youssef-El Soud, M., Groen, H.J.M., Staal-van den Brekel, A.J., Buikhuisen, W.A., Bootsma, G.P., Dammeijer, F., Tinteren, H. van, Lalezari, F., Aerts, J.G., Burgers, J.A.

Volltext bestellen